• Life Sciences Advisory Board

    Developing and driving the overall life sciences strategy in Scotland

  • Our heritage

    Many of the greatest advances in the history of medicine come from scotland

  • Scottish Life Sciences Strategy 2011

    One-page summary of the Scottish Life Sciences Strategy 2011

  • Editorial policy

    How this website is managed

  • Contact us

    Get in touch with Life Sciences Scotland

Life Sciences Advisory Board

LiSAB is a joint industry, enterprise and government strategy team that plays a crucial role in ensuring Scotland has the best possible environment for fledgling technologies and established players alike. It fosters support and discussion between key players in the life sciences sector and those responsible for government policy-making at the very highest level.

LiSAB has a very active remit; to develop and drive overall life sciences strategy in Scotland; developing an environment where ingenuity and innovation can create jobs and wealth for Scotland, as well as genuine benefits for the global community.

LiSAB consists of representatives across the spectrum of the life science community: CEOs and senior managers from pharmaceutical, biotechnology, medical devices and diagnostics companies; research organisations; Scottish Enterprise, Highlands and Islands Enterprise, the Scottish Government, Universities and the NHS.

LiSAB's remit is:

  • To set the overall strategy for the growth of the Life Sciences sector in Scotland.

  • To advise Ministers, government, Scottish Enterprise, HIE and the wider public sector on key issues the industry is facing, both in Scotland and internationally.

  • To advise on the deliverables that will help the Life Sciences industry to fulfil its growth potential.

Life Sciences Advisory Board members

Name Company/organisation
Nicola Sturgeon Deputy First Minister, Co-Chair
John Brown CXR, Axis-Shield, Roslin Foundation, Co-Chair
Rhona Allison Scottish Enterprise
Brian Bathgate Charles River
Bill Blair Excalibur and HSV Advisers
David Bowie Aircraft Medical
Geraldine Brown Astra Zeneca
David Burns Renishaw Diagnostics
Steven Dodsworth Highlands and Islands Enterprise
Anne Glover Chief Scientific Adviser
Gerry Hepburn Aptuit
Paul McBarron Cyclacel
Cameron MacDonald Controlled Therapeutics
Aileen McKechnie Scottish Government
Andrew Mearns-Spragg  Aquapharm
Andrew Morris Univ of Dundee
Chris Packard NHS Greater Glasgow & Clyde
Marie Claire Parker XstalBio
Willie Printie LifeScan
David Scott Tepnel/Gen-Probe
Jonathan Snape SCRI
Mike Stevens Chief Scientist Office
Alistair Strachan Pfizer
Dave Tudor GSK
George Zajicek Axis Shield

Downloads

  • Scottish Life Sciences Strategy

    The Life Sciences Advisory Board has refreshed its strategy to double the size of the sector in Scotland by 2020

  • Scottish Life Sciences 2010 Review

    Scotland’s life sciences community has remained resilient in the challenging global environment and the sector has continued to develop over the last 12 months

News